A study of a device that removes carbon dioxide from the blood
Part of Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests a device called PrismaLung+ that helps remove extra carbon dioxide from the blood of patients on breathing machines. It may help people whose lungs are struggling despite gentle ventilation settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are on a breathing machine (ventilator) with high carbon dioxide levels and low blood pH.
- You can safely use this device for at least 2 hours.
- You or your legal representative can sign a consent form.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an “extra-CO2 removal” breathing support approach to help protect the lungs in people with moderate ARDS, a serious lung injury. You would be on a ventilator for a short time, and the team would check whether this approach improves breathing outcomes while aiming to be safer for the lungs.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This trial tests a new way to adjust breathing machine settings for people with a lung condition called ARDS. The adjustments are based on detailed monitoring of the heart and lungs, aiming to improve recovery.
This trial tests a new way of adjusting breathing machine support based on how hard you are breathing. It may help people with low oxygen levels who need a ventilator.
This trial tests a new way to set the breathing machine's pressure support based on your muscle effort. It may help you breathe more comfortably and improve recovery.
This study tests a machine that removes carbon dioxide from the blood to help people with severe COPD breathe easier when noninvasive ventilation (a mask that helps breathing) is not enough. It aims to avoid the need for a breathing tube.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.